These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18655368

  • 1. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
    Stawerski P, Wagrowska-Danilewicz M, Stasikowska O, Gottwald L, Danilewicz M.
    Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
    [Abstract] [Full Text] [Related]

  • 2. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V.
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM.
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [Abstract] [Full Text] [Related]

  • 4. Immunoexpression of CAS protein is augmented in high grade serous ovarian tumors.
    Stawerski P, Wągrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2010 May; 61(4):219-23. PubMed ID: 21290345
    [Abstract] [Full Text] [Related]

  • 5. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y.
    Oncology; 2006 May; 71(1-2):102-10. PubMed ID: 17341890
    [Abstract] [Full Text] [Related]

  • 6. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J.
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [Abstract] [Full Text] [Related]

  • 7. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C, Macedo-Pinto IM, Maia SS, Vieira RH, Lopes CS.
    Gynecol Obstet Invest; 2005 Aug; 60(2):75-83. PubMed ID: 15785075
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR, Fonsechi-Carvasan GA, De Angelo Andrade LA, Böttcher-Luiz F.
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [Abstract] [Full Text] [Related]

  • 10. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW, Ellenson LH, Soslow RA.
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [Abstract] [Full Text] [Related]

  • 11. [Subserous gallbladder carcinoma: expression of cadherine-catenine complex].
    Roa I, Ibacache G, Melo A, Morales E, Villaseca M, Araya J, Roa J, Guzmán P, de Aretxabala X.
    Rev Med Chil; 2002 Dec; 130(12):1349-57. PubMed ID: 12611235
    [Abstract] [Full Text] [Related]

  • 12. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
    Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M.
    Oncol Rep; 2001 Dec; 8(2):249-55. PubMed ID: 11182035
    [Abstract] [Full Text] [Related]

  • 13. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ, Jang SJ, Yu E.
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
    Nozawa N, Hashimoto S, Nakashima Y, Matsuo Y, Koga T, Sugio K, Niho Y, Harada M, Sueishi K.
    Pathol Res Pract; 2006 Feb; 202(9):639-50. PubMed ID: 16843618
    [Abstract] [Full Text] [Related]

  • 15. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
    Shaco-Levy R, Sharabi S, Piura B, Sion-Vardy N.
    Acta Obstet Gynecol Scand; 2008 Feb; 87(8):868-74. PubMed ID: 18607832
    [Abstract] [Full Text] [Related]

  • 16. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R, Serra S, Asa SL.
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [Abstract] [Full Text] [Related]

  • 17. Expression and localization of e-cadherin in epithelial ovarian cancer.
    Koensgen D, Freitag C, Klaman I, Dahl E, Mustea A, Chekerov R, Braicu I, Lichtenegger W, Sehouli J.
    Anticancer Res; 2010 Jul; 30(7):2525-30. PubMed ID: 20682978
    [Abstract] [Full Text] [Related]

  • 18. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC, Moon WS.
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [Abstract] [Full Text] [Related]

  • 19. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
    Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM.
    Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
    [Abstract] [Full Text] [Related]

  • 20. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H.
    Pathol Res Pract; 2006 Oct; 202(10):713-20. PubMed ID: 16962250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.